Dr Russell, 64, who waived his right to attend the hearing, was convicted in 2023 of three offences: making indecent photographs of a child, possessing 2,280 prohibited images of a child and possessing 109 extreme pornographic images that included moving images that were grossly offensive.
After pleading guilty to making indecent photographs/pseudo-photographs of a child, possessing a prohibited image of a child, and possessing extreme pornographic image/images portraying sexual acts with an animal, Dr Russell was sentenced at Winchester Crown Court to a two-year community order, a 30-day Rehabilitation Activity Requirement, 150 hours of community service and a forfeiture and destruction order of Seagate Drive, Toshiba hard drive and Lenovo tablet.
In addition, he was required to register with the police for 5 years and made subject to a Sexual Harm Prevention Order for five years.
He was also required to pay prosecution costs of £425 and £60 victim surcharge.
Counsel for the College submitted to the Disciplinary Committee that the nature and circumstances of the offences rendered Dr Russell unfit to practise as a veterinary surgeon.
The Committee considered there to be several aggravating factors including, actual (albeit indirect) injury to an animal or child; the risk of harm to an animal or child; sexual misconduct; premeditated conduct; and, that the offences involved vulnerable children and animals.
Neil Slater, chairing the Committee and speaking on its behalf, said: “The Committee has reached the conclusion that Dr Russell’s behaviour is fundamentally incompatible with being a veterinary surgeon, namely grave offences of a sexual nature.
"Dr Russell’s behaviour was so serious that removal of professional status and the rights and privileges accorded to that status is considered to be the only means of protecting the wider public interest and of maintaining confidence in the profession.
“The Committee has not taken this decision lightly, and, lest it be misinterpreted, it has not taken it in order to satisfy any notional public demand for blame and punishment.
"It has taken the decision because, in its judgment, the reputation of the profession has to be at the forefront of its thinking and ultimately this is more important than the interests of Dr Russell.
"The decision is not simply based on the fact that these offences were of a sexual nature but because they were repeated over a significant period of time and at a time when Dr Russell must have known, on his own plea of guilty, that what he was doing was wrong.
"Further, the Committee can discern no evidence that Dr Russell has insight into the gravity of the offence he has committed.
"The Committee has therefore directed the Registrar to remove his name from the Register forthwith.”
Dr Russell has 28 days from being notified of his removal from the Register to lodge an appeal with Privy Council.
Trodax is used to treat the mature and late-immature stages of the liver fluke Fasciola hepatica in both cattle and sheep. It is also indicated for the treatment of Haemonchus contortus infections.
Findlay MacBean, Business Head for Ruminant, at Boehringer Ingelheim Animal Health said: “Manufacturing problems have led to Trodax being out of stock since late 2020 and it is with regret that we have to confirm that we are no longer able to manufacture the product.
"As one of the largest animal health businesses in the world we are committed to improving the lives and health of animals. We have a strong research and development focus, and a pipeline of potential products, including antiparasitics. We recognise that the discontinuation of Trodax may pose challenges for cattle and sheep producers where resistance to other flukicides has been confirmed.
“Our technical services team are on hand to support veterinary practice and animal health merchant customers as we make this change to our portfolio. Customers who have a technical enquiry should call 01344 746957 or email vetenquiries@boehringer-ingelheim.com.”
Boehringer says that its other wormer and flukicide brands are not affected and that Ivomec Super Injection, which contains ivermectin and clorsulon, provides an alternative treatment option for adult liver fluke in cattle and is also effective against gastrointestinal worm species, lungworm, and key external parasites.
Now, when you search Google for something which includes the word 'job' or 'jobs', Google presents an easy-to-filter list of local vacancies. You can also search in other locations.
One of the criteria for a job advert to be listed in Google for Jobs is that it must first have appeared on a webpage written with special code which allows the search engine to read the advert correctly.
VetSurgeon Jobs has been upgraded to include this code, and jobs advertised on VetSurgeon.org are now appearing on Google for Jobs.
VetSurgeon Editor Arlo Guthrie said: "We've known this was coming for some time, so we made sure VetSurgeon Jobs would be ready as soon as Google unveiled the new system.
"It has yet to be seen how widely Google for Jobs will be used by veterinary surgeons looking for a job. Back in the day, you'd have to wait for the latest copy of Vet Times to arrive in the post in order to find a job. Then came the internet, and with it a small handful of job websites worth checking for veterinary vacancies, of which VetSurgeon Jobs is one.
"Now, Google for Jobs provides one-stop search from most of the big players, although not all veterinary job boards are compatible with the new system and notably Indeed is excluded from Google for Jobs search results.
"The question now is whether jobseekers will continue to go directly to their favourite job website, or search Google first. Either way, though, you'll find jobs advertised on VetSurgeon.org!"
What do you think of the new Google for Jobs feature? Comment below.
In the study titled “Safety of early postoperative hydrotherapy in dogs undergoing thoracolumbar hemilaminectomy”, the medical records of a single referral hospital in Sweden were retrospectively reviewed to identify dogs that had been treated with hemilaminectomy for acute or chronic thoracolumbar IVDE and had commenced hydrotherapy within five days after surgery.
Information collected from the medical records included signalment, presenting clinical signs, severity of neurological signs, initiation and duration of hydrotherapy, postoperative complications and follow-up.
Postoperative complications were considered major if there was a need for hospitalisation, surgery or if the dog died or was euthanised as a direct consequence of the complication.
A complication was deemed minor if outpatient medical treatment was sufficient to rectify it.
A total of 83 dogs were included in the study.
Hydrotherapy was started within a mean of 2.7 (one to five) days after surgery and consisted of swimming without underwater treadmill (UWTM) in dogs with severe paraparesis or paraplegia.
With neurological improvement, and when supported ambulation was possible, UWTM was initiated.
Ninety-six percent of the dogs used swimming as postoperative hydrotherapy, starting with a mean of 2.7 days after surgery, fifty-seven percent of the dogs used UWTM as the postoperative hydrotherapy, starting with a mean of 13 days after surgery.
Forty-five percent of dogs used both hydrotherapeutic modalities.
Dr Abtin Morjarradi, corresponding author for the paper, said: “A total of 10 minor complications were recorded during the study period, including surgical site infection (SSI) (n=5), diarrhoea (n=4) and urinary tract infection (n=1).
Major complications were recorded in 26 dogs during the study period and included euthanasia (n=13), acute dermatitis (n=1), spinal abscess (n=1) and disc extrusion (n=1).
Reasons for euthanasia were urinary incontinence (n=5), lack of neurological improvement (n=2), clinical suspicion of progressive myelomalacia (PMM) (n=2), persistent pain (n=1), aggression (n=1) and widespread cellulitis with an abscess caudal to the right stifle without known cause (n=1).”
Abtin added: “Follow-up visits for 71 dogs were performed at a mean of 15.3 (9 to 30) days, and 68 dogs at a mean of 45.9 (30 to 111) days, after surgery.
"At the first follow-up visit 68% of the dogs were ambulatory with Modified Frankel Score (MFS) 4 or higher.
"At the last follow-up visit 97% of the dogs were ambulatory with MFS 4 or higher, with 34% demonstrating normal neurological function. None of these dogs deteriorated after the initiation time of hydrotherapy.”
Nicola Di Girolamo, Editor of JSAP, said: “Whilst previous studies indicate that early rehabilitation may be beneficial after acute spinal cord injury, the optimal timing to start hydrotherapy is unclear.
“Despite a high number of complications being recorded in the present study, it is not clear how many of these complications were directly related to the initiation time of hydrotherapy and therefore further research is required.”
The full article can be found in the December issue of the Journal of Small Animal Practice: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13412.
Reference
The new service was reported in The Times, in an article titled "How much should your vet cost? Pet owners bitten by untamed fees."
Since launch, VetHelpDirect has offered owners information to help them pick a veterinary practice, including reviews, ratings (including a value for money score), RCVS accreditation, cat/ rabbit friendly status, health plan details and how out of hours cover is provided.
It has now added some basic information about each practices' charges, specifically the first consultation fee, a dog castrate and health plans, and then categorised them according with £££££ signs to indicate how far above or below the average they sit.
Susie Samuel said: “Most practices will give out these prices over the telephone, but there’s no way for the client to find them without directly getting in touch, something people are less and less likely to want to do nowadays.
"Our research data suggests that people want to find this information online, just as they would in any other service industry.
"When they can’t find any information at all on pricing, there can be a perception of secrecy that can do damage to the vet-owner relationship.”
Susie added: “True comparison for vet practices is of course very complex and no basket of services is ever going to capture the whole complexity.
"Every practice is different, from facilities and team qualifications; to the time allotted for consultations; to monitoring equipment for surgery; and of course the level of investigations undertaken which can also vary from vet to vet.”
“We can’t solve all this straight away but we started from a good place, over the years we have built up more information about vet practices than any other website.
"The aim is to provide commonly requested prices for owners to easily access and to add more and more detail on the vet practices over time so that owners can make the most informed choice on the vet that's most appropriate for them and their pet”.
VetHelpDirect says it will soon be adding prescription fees and out of hours consultation, and a much wider range of species-specific fees in the near future.
The company also points to the Competition and Markets Authority investigation into pricing in the UK, highlighting that in its 2019 Report into Funerals in the UK, the CMA noted that weaknesses in the sector included the fact that less than 40% of funeral directors posted any form of pricing online, and those that did were frequently not in a form that made for easy comparison.
Susie says the veterinary sector has an even lower rate of online pricing transparency.
To add your pricing information to VetHelpDirect, email: info@vethelpdirect.com.
COMMENT
Whilst greater transparency over pricing in almost any field is surely to be welcomed, it seems questionable whether comparing prices for consultations and standard procedures will be of much help to pet owners, because things like the level of investigations, how defensively a clinician practises and the owner's own relationship with risk are likely to have a far greater impact on the bill than whether a consult costs £20 more or less up the road.
There is perhaps also a risk of practices rated as '£££££ / more expensive than average' will be seen as just that. Expensive and nothing more.
It's not like a restaurant where £££££ usually means particularly delicious.
Whilst this may not matter much whilst so many practices are having to turn away business, it may become more important in the future.
Discuss here.
Southfields Veterinary Specialists in Laindon, which is part of the Linnaeus Group, has recruited the highly-respected Dr Fabio Stabile to join its neurology and neurosurgery unit.
Fabio will start working at the practice's neurology and neurosurgery unit in January, with another specialist, Dr Ane Uriarte from Tufts University in the USA, joining in the spring.
Fabio said: "I am delighted to be joining Southfields Veterinary Specialists in the new year as a Consultant in neurology and neurosurgery.
"It is an extremely exciting time to be joining Southfields and their team of renowned and successful specialists, especially as this is a strong time of growth in their neurology/neurosurgery discipline.
"The imminent move of the Southfields team to a new, state-of-the-art hospital with the possibility of creating a new phenomenal environment and ‘family’ is really exciting!"
Fabio graduated from Padova University in 2003 before completing a three-year PhD in veterinary clinical sciences at the university supervised by Dr Marco Bernardini DVM, DECVN.
In 2009, he moved to the UK and started a Residency in Neurology and Neurosurgery at the Animal Health Trust under the supervision of Dr Luisa De Risio DVM, FRCVS, PhD, DECVN.
Fabio added: "My main area of interest in veterinary neurology and neurosurgery are epilepsies and the treatment of epilepsy and any neurosurgeries.
"Improving antiepileptic treatment for our patients has constituted my main focus of clinical research. It’s a subject I strongly care about."
Dr Stabile also enjoys passing on the benefits of his expertise and experience to the next generation of veterinary surgeons. He has presented several clinical research abstracts at international and European conferences and he is the author of multiple publications in peer reviewed journal Veterinary Services.
"I have always been extremely keen on teaching and I enjoy delivering lectures to young colleagues in training and to colleagues working in general practice."
The first charge related to his conviction on two counts of common assault by beating two individuals at an incident in December 2016, as a result of which he was made subject to a community order and a restraining order, as well as being fined and made to pay a victim surcharge and costs.
The second charge related to him undertaking, or attempting to undertake non-emergency surgery on the eyelid of one of the individuals referred to in the first charge, and administering, or attempting to administer, a Prescription-Only Veterinary Medicines to the same person.
The third charged related to an allegation that he had supplied the same individual with a Prescription-Only Medication other than in accordance with a valid prescription.
The second charge and third charges related to incidents which occurred some considerable time before the assault, not as a consequence of it.
At the outset of the hearing Mr Sutcliffe admitted the first and second charges against him and that these constituted serious professional misconduct. He denied the third charge. In relation to that charge the Committee found that, having considered the totality of the evidence, it was unable to be sure that the College had proved the allegation to the requisite standard of proof, namely so that the Committee was sure. Accordingly Charge 3 was dismissed.
The Committee decided that the convictions in the first charge rendered Mr Sutcliffe unfit to practise veterinary surgery and that his conduct in Charge 2 constituted serious professional misconduct.
The Committee then went on to consider sanction.
The Committee considered the aggravating features for both charges. For the first charge it considered the actual injury to one of his victims and risk of injury to the other, noting also that both of his victims were vulnerable people and one was a child, and that the overall incident during which the assaults occurred lasted over a seven hour period.
For the second charge, aggravating factors were that the non-emergency surgery performed by Mr Sutcliffe was wholly inappropriate, that there was a risk of injury to the individual on whom he performed the surgery and that his conduct was reckless.
The mitigating factors considered by the Committee were that Mr Sutcliffe recognised the gravity of the findings against him and demonstrated insight into the allegations, that the incident in charge 1, though prolonged, was an isolated one, that the incident in charge 2 was consensual and did not result in actual harm and that neither charge had any connection with Mr Sutcliffe’s veterinary practice, nor did they affect client care or animal welfare.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "As recognised by the Committee, the respondent has displayed insight as to the seriousness of his behaviour. Having regard to the evidence of all the character witnesses and the written testimonials the Committee accepts that the respondent’s conduct as set out in charges 1 and 2 was wholly out of character and, therefore, there is no significant risk of repeat behaviour. The Committee considers that the respondent would be fit to return to practise, having regard to his excellent track record as a veterinary surgeon to date, after any period of suspension.
"Having regards to the aggravating and mitigating factors in this case, the Committee has decided that it is sufficient to maintain public confidence in the profession and declare and uphold proper standards of conduct to give a direction for suspension of the respondent’s name from the Register of Veterinary Surgeons.
"The Committee considers that the period of suspension must be sufficient to mark the seriousness of the charges but must be proportionate and fair in the circumstances of the case. The Committee has therefore concluded that the appropriate period of suspension is six months."
Mr Sutcliffe has 28 days from being informed of the Committee’s decision to appeal to the Privy Council.
Clinicians at the Queen Mother Hospital for Animals at the Royal Veterinary College have become the first team in the UK to successfully treat acromegaly in a cat with hypophysectomy surgery.
According to the RVC, this make it the first centre in the UK, and only the fourth in the world, to offer this procedure. The patient groups that might benefit from this RVC-exclusive procedure include cats and dogs with non-functional pituitary tumors, cats and dogs with hyperadrenocorticism (Cushing's disease) and cats with acromegaly or hypersomatotropism.
The RVC says removing the pituitary gland and the associated tumour which causes acromegaly or hyperadrenocorticism is the gold standard treatment in humans suffering from these diseases since it offers the greatest chance of a complete cure for the disease.
Prior to the RVC offering surgical treatment, the only treatment options available for acromegalic cats in the UK were radiation therapy or simply treatment of the resulting diabetes mellitus. The latter can prove extremely difficult and frustrating and the former unpredictable, unreliable and/or ineffective. Even when a complete response to the radiation therapy eventually occurs, hormonal abnormalities usually persist.
Dr Stijn Niessen, leading the hypophysectomy team at the Royal Veterinary College, said: "I'm extremely proud to be able to offer this unique surgery for the first time in the UK at the RVC. As a relatively new and innovative procedure in veterinary medicine there are risks involved, as is recognised with every form of neurosurgery of this level. However, despite these risks, this surgery does offer owners a chance for the best possible result for their pet using a single procedure. Hypophysectomy therefore represents the most elegant treatment method currently available enabling complete removal of the brain tumor and normalisation of damaging excessive hormone levels that are causing hormonal diseases like acromegaly and hyperadrenocorticism.
"Especially when a pituitary tumor is diagnosed late, the alternative treatment method of radiation therapy might well take too long to take effect and devastating neurological signs might occur due to the pressure of the pituitary tumor on the surrounding brain. In such cases, hypophysectomy can make an instant difference in relieving that pressure. However, in general, we would advocate the procedure to be considered as soon as possible following diagnosis, thereby preventing the animal's body from becoming more and more negatively affected by the excessive hormone levels associated with pituitary diseases like acromegaly and hyperadrenocorticism."
Dr. Niessen, a European Veterinary Specialist in Internal Medicine with research interests in diabetes and endocrinology and world-expert in acromegaly, will be selecting the patients suitable for the new treatment, preparing them for surgery and managing the aftercare programme. The longer-term aftercare programme will include hormone replacement treatment administered through eye-drops (usually temporarily) and tablets (permanent) to manage the hormone production lost through removal of the pituitary gland.
The surgery itself will be performed by Patrick Kenny, a European and American Specialist in Veterinary Neurology and Neurosurgery.
The RVC says the surgery would not be possible without the multidisciplinary approach at the Queen Mother Hospital for Animals, which includes the Internal Medicine, Neurology and Neurosurgery, Diagnostic Imaging, Anaesthesia and Emergency and Critical Care teams as well as a team of highly qualified nurses.
To support ongoing research in this field, the Royal Veterinary College is offering free blood tests for all diabetic dogs and cats which include fructosamine evaluation and screening tests for the presence of acromegaly in cats. Cats that record high hormone levels indicative of acromegaly will qualify to undergo a free CT scan for confirmation. If acromegaly is confirmed, all possible treatment options will be discussed with the client, including the hypophysectomy procedure. To request a free blood test for a patient please visit: www.rvc.ac.uk/cic
Veterinary surgeons currently managing a cat or dog with a pituitary tumor who are considering referral of this case can also contact Dr Stijn Niessen for further information at the QMHA on 01707 666365 or at qmhreception@rvc.ac.uk
Rabbits are the third most commonly anaesthetised pet in the UK, however they have a seven times greater overall risk of perioperative death than dogs1.
Jurox says Alfaxan 10mg/ml solution for injection provides a wide safety margin, an excellent cardio-respiratory profile and is dosed to effect, making it an excellent choice for the anaesthetic induction of rabbits.
The company also says Alfaxan provides smooth and rapid induction and recovery, painless administration and good muscle relaxation with low impact on ventilation and blood pressure.
Richard Beckwith, country manager of Jurox (UK) Ltd said: "Rabbits are a growing pet population and increasingly play a more important part in UK vet practices, which is why Jurox has invested in research in this species.
"We are happy we can now support our vet and nurse clients by providing a new and reliable choice for induction of anaesthesia in pet rabbits that has been extensively trialed and researched.
"Alfaxan is a very versatile product as it is convenient for any type of situation, whether it is surgery on healthy animals or high risk patients such as pet rabbits. With Alfaxan we hope to make a contribution to the future of veterinary anaesthesia in the UK and are confident our clients will be able to deliver the best practice anaesthesia they believe in."
For more information, visit: Alfaxan.co.uk. Alternatively, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
References
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
VetSurgeon member Andrew Dobson of The Barn Equine and Large Animal Practice in Great Wakering, Essex has won the inaugural Petplan Equine Vet of the Year Award.
Owners and riders all over the UK were invited to send in nominations for this new people's award. A short list of three finalists was then drawn up and the winner selected by an independent panel consisting of Jo Whitaker, brand manager for Petplan Equine; Alison Bridge, editor-in-chief of Horse&Rider magazine; David Stickels, head of fundraising for the AHT, and David Dugdale, president of the British Equine Veterinary Association (BEVA).
Andrew was nominated by a number of his grateful clients and their glowing testimonials impressed the judges enough to give him the edge over his closest rivals for the title.
"This award is intended to recognise the amazing hard work and commitment of people within the equine veterinary profession and those who provide outstanding service to horse owners," explained Jo Whitaker. "We received some very strong nominations and all three finalists are clearly exceptional vets. Andrew Dobson was nominated by a number of his clients and they all stressed his professionalism and devotion to the horses in his care and how he regularly goes beyond the call of duty in making sure that both horses and owners are given the very best treatment."
Suzy Dorey was among the clients to nominate Andrew: "When I came across Andy I realised that he was an old fashioned type of vet and had the time and patience to deal with the horses and just as importantly the clients. I cannot recommend Andy highly enough and would like to see him given recognition of some sort for being a dependable, down-to-earth vet."
Andrew said: "I am absolutely stunned. I'm so honoured and amazed to of received the Petplan Equine Vet of the Year award. I really enjoy what I do and would like thank all my clients, Petplan Equine, the Animal Health Trust and Horse&Rider for their support."
Taking place at Code Node, VSGD Live will bring together 300 veterinary professionals, offering TED-style talks, Q&A sessions, small group workshops, panel discussions, a VSGD art gallery, awards, and time for networking.
On day one, the event will explore the options open to veterinary surgeons, with talks from those who've stayed in practice, left the profession or diversified their career paths.
There to share their experiences will be Julie Ross (From the clinic to consultancy), Niall Connell (Discovering life after ill health retirement), James Greenwood (Presenter, vet, potter), Jade Statt (Starting Streetvet), Greg Dickens & Guen Bradbury (Work to innovate), Chris Tufnell (Advocating for the profession in practice), Rob Petitt (Mind over matter and surgery), Kimberly Wells (Talk is cheap action is priceless lessons from welfare and Cal Major (Paddling against plastic).
On day two, there will be small group workshops and panel discussions to help you build the confidence and knowledge to move into a new career path or gain a new skill. Subjects include:
Working out what you want: Vet Your Life!
Stop selling yourself short: CV clinic
Taking an idea to business
Practice makes perfect: Starting a veterinary business
Becoming a portfolio professional or a part-time pro
Working in science and communications
Careers in education
Carving out a charitable career
Beyond veterinary: working in the civil service
Locumming: be the independent professional
Lunch on both days is included, as well as drinks and nibbles on Saturday night.
All ticket holders will also receive a follow up e-book with top tips, videos and advice from the inaugural VSGD LIVE! event.
505 people took part in the survey in August 2019, of which 85% were receptionists. The remainder were RVNs, VCAs or practice managers with some front desk responsibility.
The survey found that 45% were paid between £8 and £9 per hour, with 9% more falling into this salary bracket than in 2018. 5.32% were paid £8 or less per hour.
The Real Living Wage is a figure calculated from the costs of a basket of household goods and services by the Living Wage Foundation, and voluntarily paid by its 6000-odd member companies in the UK. The Living Wage Foundation argues it is a better measure of what people need to get by on than the Minimum Wage (£7.70 for those aged between 21 and 25) or the National Living Wage (£8.21 for those over 25).
63% of veterinary receptionists said they were unsatisfied with their pay. However, it was not the biggest cause of dissatisfaction uncovered by the survey. 67% were dissatisfied with the recognition of the value of their role, and 69% with the career progression options open to them.
70% of respondents said they would like to do more CPD and that the main benefit would be to clients and patients. However, 43% of receptionists said there is no time allowance set aside for them to complete CPD.
Co-founder of BVRA and Honorary Associate Professor In Veterinary Business, Nottingham University, Brian Faulkner (pictured right) said: "A large part of the client experience is centred around the waiting room and receptionist area and our members work hard to ensure that experience is positive.
"We have an increasing number looking to upskill and the appetite for CPD is clearly there. If we can envisage a scenario where the minimum wage is set at £10.50 an hour, that would mean that around 65% of veterinary receptionists would need a pay increase.
"I don't think any of us believe that veterinary receptionists are currently doing an unskilled job and a key mission of BVRA is to achieve greater recognition of the value they bring to practices, both as colleagues and commercially."
On 23rd October, Dr Hannah Capon MA Vet MB MRCVS will present 'OA management: more than just drugs', in which she will consider how best to manage canine osteoarthritis in first opinion practice and offer practical tips on how veterinary surgeons and nurses can help owners manage the condition better.
On 6th November, Dr Zoe Belshaw MA Vet MB PhD Cert SAM Dip ECVIM-CA AFHEA MRCVS (pictured right) will present 'Increasing compliance in OA treatment', during which she will discuss some of the reasons behind poor compliance and strategies to improve compliance by owners of dogs with osteoarthritis.
Forte Healthcare’s head of technical services and marketing, Dr Lucy Chadwick said: "We are delighted to have two well-recognised experts to deliver these webinars and we’ve made sure that they will be as equally relevant for vet nurses as they are for practising vets.
"For anyone who cannot join the live screenings, the webinars will be made available to watch on demand for a limited time after they are shown."
To register for the webinars, visit: www.fortehealthcare.com/oa-2018
Merial has launched the latest edition of its Osteoarthritis (OA) Expert series, covering key aspects of management such acute OA flare up.
Produced by Steven J Butterworth MA VetMB CertVR DSAO MRCVS from Weighbridge Referral Centre Swansea, the update advises on key issues, including when surgery might be necessary. Steven is an RCVS Recognised Specialist in Small Animal Surgery (Orthopaedics) and this latest contribution to the guide also looks at patient monitoring and factors such as lifestyle, diet, physiotherapy and the role of NSAIDs.
Previcox product manager Claire Edmunds said: "The quarterly updates are each written by an expert in their field and provide an opportunity for practising vets to update their OA expertise.
"As with every update vets can put their knowledge to the test, and one lucky winner will receive £500 worth of CPD vouchers. Released quarterly, the updates have proved extremely popular. Each paper has a related quiz containing key questions from the discussion and the winner will be the first correct entry drawn at random."
The company will produce further editions next year covering topics including conservative management of canine osteoarthritis and rehabilitation.
If you haven't received a manual and would like a copy, please contact your local Merial territory manager or call the customer hotline on 0870 6000 123.
The joint submission points to evidence from recent surveys indicating a current workforce shortage of 11% in small animal practice and an overall deterioration in the ability of practices to hire suitably qualified staff.
Following the exit from the EU, existing shortages will likely worsen, whilst changes in trade could increase the demand for veterinary skills, producing a shortfall in the UK’s capacity to ensure animal health and welfare, food safety and public health.
Placing the veterinary profession on the Shortage Occupation List would reduce restrictions on recruiting veterinary surgeons from abroad, something the response says will become a necessity post Brexit.
Currently about half of vets registering each year in the UK are graduates from the EU. If there are no appropriate immigration measures in place when the UK leaves the EU, this EU contribution could decline, leaving a large gap in the veterinary workforce. Research among BVA members has indicated that since the EU referendum, about one fifth are reporting that recruitment has already become harder. Meanwhile, a study commissioned by the RCVS has shown that nearly a third of veterinary surgeons and veterinary nurses whose nationality is non-UK European are considering a move back home.
The BVA / RCVS response highlights that although the veterinary profession is relatively small, it performs a range of roles that are vital to the UK’s economy and maintaining standards in society. Agriculture and food production would suffer from a lack of veterinary input, potentially reducing its livestock outputs worth £12.7bn in 2016, whilst the equine industry and aquaculture would also struggle. The companion animal veterinary market, that has a turnover of £3 billion, could experience significant losses due to workforce shortages.
Veterinary surgeons from the EU make a particularly significant contribution to critical roles in public health with estimates suggesting that 95% of Official Veterinarians working in abattoirs are from overseas and the large majority of these are from the EU. Reducing the veterinary presence in slaughterhouses would increase the risk of food fraud, provide the potential for animal welfare breaches and remove a level of public health reassurance.
While the number of UK veterinary graduates has increased year-on-year from the established veterinary schools, with potentially more schools in the pipeline, it is unlikely that UK universities can meet this increased demand in the short timeframe required. BVA, RCVS and Defra recently launched the Veterinary Capability and Capacity Project (VCCP) to help ensure the veterinary sector can continue to play its role in society.
BVA Senior Vice President Gudrun Ravetz said: "Our members have been reporting problems with recruitment and retention of vets for several years and this situation will only worsen under Brexit unless appropriate measures are in place. Vets are vital to our society. Across the UK vets are needed to certify imports and exports, conduct cutting-edge research, prevent disease outbreaks, ensure food safety in abattoirs and achieve our world leading standards in animal welfare.
"We are setting out a very strong case to add the profession to the Shortage Occupation List now to help us manage the immediate shortfall in critical veterinary roles, while the UK negotiates a longer term immigration policy that must meet the UK’s veterinary workforce needs post-Brexit without creating disproportionate administrative burdens for veterinary businesses."
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The first of our recently published Brexit Principles is that ‘vital veterinary work continues to get done’. In order to ensure this is met we want the Government to recognise that there are significant current and potential shortages in the profession that can only be mitigated by putting it on the Shortage Occupation List so that animal health and welfare and public health is safeguarded.
"Our ideal outcome is that EU veterinary surgeons currently living and working in the UK are allowed to stay indefinitely and that, in terms of any post-Brexit immigration system, graduates of European schools accredited by the European Association of Establishments for Veterinary Education (EAEVE) are allowed to work here with the minimum of restrictions."
More information is available in BVA/RCVS’s full response to the Migration Advisory Committee’s Call for Evidence:www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Get_involved/Consultation_archive/Migration%20Advisory%20Committee%20BVA%20RCVS%20Submission%20FINAL.PDF
Elanco has launched a new poultry tonic designed to support birds during the most demanding periods of productivity: during growth and peak laying.
The launch follows Elanco's acquisition of Janssen Animal Health and its existing poultry poultry tonic, which Elanco has improved.
Elanco Poultry Tonic HD Plus contains two new ingredients: a vitamin D3 metabolite and a natural antioxidant blend.
Elanco says the new product could prove just the tonic for the poultry industry in the face of rising fuel and feed costs. One study has apparently demonstrated as much as a 5:1 return on investment can be made as a result of supplementing the D3 metabolite alone.1According to the company, the vitamin D3 metabolite has been shown to increase egg weights (by around 2 per cent) and improve feed conversion and feed intake. It is more available to the body than vitamin D3, which plays a role in calcium metabolism (and therefore egg production). The benefits are significant for commercial egg producers but also for hatcheries, as egg size correlates with chick weight. Elanco says the metabolite can also improve bone strength, potentially resulting in healthier, more robust poults.The new antioxidant blend contains natural preparations of vitamins as well as more complex antioxidants found in fruits and vegetables, such as flavanoids, polyphenols and carotenoids. It also contains nucleotides and sulphur containing amino acids, methionine and lysine. Elanco's new Poultry Tonic HD Plus is suitable for layers, broilers, breeders and turkeys and is available from veterinary wholesalers and animal health distributors. The company is also launching Game Bird Tonic HD Plus at the same time.
1. SOTO-SALANOVA MF MOLINERO A, Efficacy of the use of Hy-D® in laying hens, XI th European Symposium on the Quality of Eggs and Egg Products 191 Doorwerth, The Netherlands, 23-26 May 2005
RSA has confirmed the initial 27 practices that have joined its new Preferred Referral Network, launching today.
The creation of the network means that whilst veterinary surgeons can continue to appoint referral practices as they do now, owners of animals needing a non-emergency referral outside the RSA network may need to pay £200 towards the cost of treatment.
The new rules currently apply to holders of policies issued by Tesco Bank and MORE TH>N, however RSA says it is in discussion with other insurance brands about adopting the new network.
RSA says the Preferred Referral Network will enable it to provide competitively priced products and deliver a range of benefits for customers including:
The company is highlighting the fact that its new network fields 178 RCVS, EBVS or AVMA recognised specialists, 49 Diploma holders and 71 Certificate holders or Advanced Practitioners, working at a mixture of large, multi-disciplinary centres (including five with links to university teaching hospitals), independents and corporates.
RSA says that over the last 12 months, vets have directed more than half of all RSA cases to the 27 practices in its network.
Bill Paton, Claims Director for UK and Western Europe said: “We are delighted to have twenty seven practices from around the UK join our preferred referral network. This is a huge step forward and will enable us to continue to provide competitively priced insurance cover with access to the highest standards of veterinary treatment and care.
"We expect further practices to join the Network in due course and we are actively engaged in discussions with a number of referral practices of varying size and scale, which have expressed an interest in joining."
The 27 referral practices are:
South East
South West
Midlands
North West
North East
East
Scotland
* referral arrangements still being finalised
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).
As a result of the new partnership, customers of Bought By Many will have access to free video consultations with UK-registered veterinary surgeons via the FirstVet app.
In their blurb, the companies say that: "Many common pet health issues can be treated in the comfort of their own home, meaning owners only need to take their pet to the vet when absolutely necessary. Bought By Many customers can save time, money and potential stress to their pet by using the free FirstVet service. When a referral to a local vet is needed, FirstVet provides detailed notes of the initial consultation to both the owner and the vet."
David Prien, FirstVet’s CEO & co-founder, said: "FirstVet couldn't be more excited to offer our veterinary video consultation service together with Bought By Many in the UK.
"From our first meeting with the Bought By Many team, we knew that our values were aligned. We both share a mission to bring the best that technology has to offer both to pet owners and to the veterinary care process.
"Offering pet owners the chance to speak face-to-face with an experienced veterinarian via a video call is a great way to make sure that all pets are getting the right treatment, as fast as possible, in the right location."
For more information on Bought by Many, visit boughtbymany.com/pet-insurance.
Alexander Reiter and Margherita Gracis formed the new editorial team and selected an international collection of leaders in their fields of expertise to contribute to this latest edition.
Alexander said: "This is a timely publication, as veterinary dentistry is a field that continues to grow in importance for the general veterinary practitioner. We found it important to add 'Oral Surgery' to this new edition, as many procedures performed in and around the mouth involve surgical techniques."
The BSAVA Manual of Canine and Feline Dentistry and Oral Surgery, 4th edition, is an accessible source of core information for general small animal veterinary surgeons, nurses/technicians and students interested in developing their theoretical knowledge and practical skills in dentistry and oral surgery.
The manual is now available from the BSAVA website (www.bsava.com/shop), the BSAVA Library (www.bsavalibrary.com/manuals), or by phone: 01452 726700.
For the research, the medical histories of 188 Basset Hounds and 270 Dachshunds presenting to CVS’ Dovecote Veterinary Hospital and Chestergates Veterinary Specialists, and the University of Ghent were retrospectively assessed.
Information included signalment, whether the dog had received a diagnosis of TL-IVDE, the duration of clinical signs, affected discs and anatomical region and the neurological grading at presentation and discharge.
Basset Hounds and Dachshunds are both chondrodystrophic breeds which are predisposed to IVDE.
However, the study found 77.4% of Dachshunds had presented with IVDE, compared to only 36.2% of Basset Hounds.
Dachshunds also presented earlier (66.5 months) compared to Basset Hounds (median 87.5 months).
Dachshunds had a lower proportion of midlumbar IVDE and were more frequently non-ambulatory at discharge than Basset Hounds.
In addition, Dachshunds were more likely to be paraplegic without sensation at presentation than Basset Hounds (16/154 Dachshunds compared to just one Basset).
The Basset Hound is the largest chondrodystrophic breed and the physical characteristics of this larger body conformation may have benefits, with previous studies suggesting the protective effects of being a larger dog2.
One hypothesis is whether breed conformation and anatomy – the relative height/weight ratio - influences the severity and occurrence of IVD and points to a link between the size of the patient and the space in the vertebral canal.
A smaller spinal cord versus vertebral canal ratio in the Basset Hound may indicate a less compressive lesion.
Sergio Gomes, Head of Neurology and specialist in veterinary neurology at Dovecote Veterinary Hospital, who led the study, said: “This is the first time that IVDE data for Basset Hounds has been directly compared with that for Dachshunds.
“We now need to look closely at the conformation and anatomy of the Basset Hound to see what learnings we can take.
"This could have positive future implications for Dachshund breeding programmes, so that longer term we can try to minimise this painful and common canine condition.”
The Royal College of Veterinary Surgeons has launched an online quiz to test its members' knowledge of the Guide to Professional Conduct.
The Guide outlines what is acceptable professional and ethical behaviour for veterinary surgeons. It is developed and maintained by the Advisory Committee of the RCVS, which, in addition to veterinary members of RCVS Council, also includes lay members, a member of the Veterinary Nurses Council, and independent (ie non-Council) veterinary surgeons. The Guide is the benchmark against which a veterinary surgeon is judged, by both the Preliminary Investigation and Disciplinary Committees.
The quiz, which was road-tested at the London Vet Show on 6-7 November, is anonymous, but the College will be collating data on results to help focus future communications activities and see where extra guidance may be required.
On completion of the quiz, it is possible to review answers and view the relevant section of the online Guide.
The quiz is aimed at veterinary surgeons: if it's a success, a version for Registered Veterinary Nurses will follow.
To try the quiz, visit www.rcvs.org.uk/guidequiz It will initially be online for three months and reviewed thereafter.
Amflee Combo, a POM, is being launched by a newcomer to the UK market, a Slovenian company called Krka (pronounced kirka). The company says it plans to introduce a vast range of small and production animal products onto the UK market in the next few years.
Killian Gaffney, Head of sales and marketing at Krka, says the company intends to support UK veterinary surgeons by offering high quality products and by building business relationships that will help protect veterinary incomes, at the same time as offering good value to their customers.
Killian said: "Amflee Combo has some unique features that we believe will set it apart from the competition. We know the combination of the two active ingredients in Amflee Combo is very effective for the treatment of fleas, ticks and biting lice and as part of a treatment strategy for flea allergy dermatitis in dogs and cats. S-methoprene is also effective against flea eggs and larvae in the environment.
"However, these ingredients can be susceptible to degradation when subjected to light and moisture, which is why each Amflee Combo pipette comes in its own special foil wrapper. The pipettes have also been designed for convenience of use, since we know that only 22% of owners apply spot-ons correctly1."
A range of product and client literature to support the use of Amflee Combo is available by calling 01753 722 150.
Amflee Combo is available in a variety of packs for cats and different sized dogs, containing either three or six pipettes. The recommended treatment is one pipette every four weeks.
Further information about Amflee Combo or Krka is available at www.krka.co.uk
1 El veterinario ante el cambio climatico Argos 107, 2010.
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.